EP Patent

EP2100877A1 — 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs

Assigned to Janssen Pharmaceutica NV · Expires 2009-09-16 · 17y expired

What this patent protects

The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and their use as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

USPTO Abstract

The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and their use as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

Drugs covered by this patent

Patent Metadata

Patent number
EP2100877A1
Jurisdiction
EP
Classification
—
Expires
2009-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.